Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Andreeff

Showing results (291-300 of 315) with videos related to

Pageof 32
Sort By:
Oncogene|January 30, 2007
MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemiaR Garzon, F Pichiorri, T Palumbo, et al.
Oncogene|May 13, 2022
Correction to: MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemiaR Garzon, F Pichiorri, T Palumbo, et al.
Blood|February 25, 1999
Expression and function of leptin receptor isoforms in myeloid leukemia and myelodysplastic syndromes: proliferative and anti-apoptotic activitiesM Konopleva, A Mikhail, Z Estrov, et al.
Apoptosis : an International Journal on Programmed Cell Death|December 17, 2013
Apoptosis repressor with caspase recruitment domain is regulated by MAPK/PI3K and confers drug resistance and survival advantage to AMLP Y Mak, D H Mak, H Mu, et al.
Cell Death and Differentiation|April 28, 2007
Novel role of HDAC inhibitors in AML1/ETO AML cells: activation of apoptosis and phagocytosis through induction of annexin A1Y Tabe, L Jin, R Contractor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Topotecan and cytarabine is an active combination regimen in myelodysplastic syndromes and chronic myelomonocytic leukemiaM Beran, E Estey, S O'Brien, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 1, 1997
S phase determination in intact colonic crypts by histone H3 messenger RNA in situ hybridization and confocal microscopyH Konishi, G Steinbach, N H Terry, et al.
Leukemia|November 9, 2011
MEK inhibition enhances ABT-737-induced leukemia cell apoptosis via prevention of ERK-activated MCL-1 induction and modulation of MCL-1/BIM complexM Konopleva, M Milella, P Ruvolo, et al.
Leukemia|July 18, 2024
Retraction Note: MEK inhibition enhances ABT-737-induced leukemia cell apoptosis via prevention of ERK-activated MCL-1 induction and modulation of MCL-1/BIM complexM Konopleva, M Milella, P Ruvolo, et al.
Oncogene|August 12, 2014
GD3 synthase regulates epithelial-mesenchymal transition and metastasis in breast cancerT R Sarkar, V L Battula, S J Werden, et al.
Pageof 32

Showing results (291-300 of 315) with videos related to

Sort By:
Pageof 32
Oncogene|January 30, 2007
MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemiaR Garzon, F Pichiorri, T Palumbo, et al.
Oncogene|May 13, 2022
Correction to: MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemiaR Garzon, F Pichiorri, T Palumbo, et al.
Blood|February 25, 1999
Expression and function of leptin receptor isoforms in myeloid leukemia and myelodysplastic syndromes: proliferative and anti-apoptotic activitiesM Konopleva, A Mikhail, Z Estrov, et al.
Apoptosis : an International Journal on Programmed Cell Death|December 17, 2013
Apoptosis repressor with caspase recruitment domain is regulated by MAPK/PI3K and confers drug resistance and survival advantage to AMLP Y Mak, D H Mak, H Mu, et al.
Cell Death and Differentiation|April 28, 2007
Novel role of HDAC inhibitors in AML1/ETO AML cells: activation of apoptosis and phagocytosis through induction of annexin A1Y Tabe, L Jin, R Contractor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Topotecan and cytarabine is an active combination regimen in myelodysplastic syndromes and chronic myelomonocytic leukemiaM Beran, E Estey, S O'Brien, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 1, 1997
S phase determination in intact colonic crypts by histone H3 messenger RNA in situ hybridization and confocal microscopyH Konishi, G Steinbach, N H Terry, et al.
Leukemia|November 9, 2011
MEK inhibition enhances ABT-737-induced leukemia cell apoptosis via prevention of ERK-activated MCL-1 induction and modulation of MCL-1/BIM complexM Konopleva, M Milella, P Ruvolo, et al.
Leukemia|July 18, 2024
Retraction Note: MEK inhibition enhances ABT-737-induced leukemia cell apoptosis via prevention of ERK-activated MCL-1 induction and modulation of MCL-1/BIM complexM Konopleva, M Milella, P Ruvolo, et al.
Oncogene|August 12, 2014
GD3 synthase regulates epithelial-mesenchymal transition and metastasis in breast cancerT R Sarkar, V L Battula, S J Werden, et al.
Pageof 32